Two biotechs are teaming up to deliver cholesterol-busting mRNA to clogged arteries. | Two biotechs are teaming up to deliver ...

Spain-based Asabys Partners has closed a fund of 180 million euros ($200 million), money that will go toward 12 to 15 ...

AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That ...

The NIH has found evidence of research misconduct against Eliezer Masliah, M.D., the longtime head of the National Institute ...

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...

Merck & Co. has picked up options on two Evaxion vaccine candidates, paying $3.2 million and dangling more than $1 billion in ...

On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Partners is proving it can go toe-to-toe with ...

In July, Biogen and Sage reported the failure of GABAA receptor positive allosteric modulator SAGE-324, also called BIIB124, ...

BioAge Labs is bringing in almost $200 million via its Nasdaq IPO this morning, with the proceeds earmarked for taking its ...

Amid the genetic medicines arms race, Flagship Pioneering is unveiling a new company to help biotechs fine-tune the precision ...

Enanta Pharmaceuticals has linked its respiratory syncytial virus (RSV) antiviral to significant reductions in viral load and ...

Two of the top 10 largest medtech companies will partner together on robotic head and spine procedures, with Medtronic ...